Rankings
▼
Calendar
PHIO Q2 2020 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$779,000
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-36.40
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$20M
Total Liabilities
$2M
Stockholders' Equity
$18M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$779,000
-$1M
+32.0%
Operating Income
-$2M
-$2M
+18.9%
Net Income
-$2M
-$2M
+17.8%
← FY 2020
All Quarters
Q3 2020 →